172 related articles for article (PubMed ID: 15615772)
1. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
Ertekin-Taner N; Ronald J; Feuk L; Prince J; Tucker M; Younkin L; Hella M; Jain S; Hackett A; Scanlin L; Kelly J; Kihiko-Ehman M; Neltner M; Hersh L; Kindy M; Markesbery W; Hutton M; de Andrade M; Petersen RC; Graff-Radford N; Estus S; Brookes AJ; Younkin SG
Hum Mol Genet; 2005 Feb; 14(3):447-60. PubMed ID: 15615772
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.
Ertekin-Taner N; Allen M; Fadale D; Scanlin L; Younkin L; Petersen RC; Graff-Radford N; Younkin SG
Hum Mutat; 2004 Apr; 23(4):334-42. PubMed ID: 15024728
[TBL] [Abstract][Full Text] [Related]
3. No association of a non-synonymous PLAU polymorphism with Alzheimer's disease and disease-related traits.
Papassotiropoulos A; Tsolaki M; Wollmer MA; Molyva D; Thal DR; Huynh KD; Tracy J; Staehelin HB; Monsch AU; Nitsch RM; Hock C
Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):21-3. PubMed ID: 15558716
[TBL] [Abstract][Full Text] [Related]
4. Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2.
Finckh U; van Hadeln K; Müller-Thomsen T; Alberici A; Binetti G; Hock C; Nitsch RM; Stoppe G; Reiss J; Gal A
Neurogenetics; 2003 Aug; 4(4):213-7. PubMed ID: 12898287
[TBL] [Abstract][Full Text] [Related]
5. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
Pesaresi M; Batelli S; Prato F; Polito L; Lovati C; Scarpini E; Quadri P; Mariani C; Albani D; Forloni G
Neurobiol Dis; 2007 Mar; 25(3):609-13. PubMed ID: 17174555
[TBL] [Abstract][Full Text] [Related]
6. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Riemenschneider M; Konta L; Friedrich P; Schwarz S; Taddei K; Neff F; Padovani A; Kölsch H; Laws SM; Klopp N; Bickeböller H; Wagenpfeil S; Mueller JC; Rosenberger A; Diehl-Schmid J; Archetti S; Lautenschlager N; Borroni B; Müller U; Illig T; Heun R; Egensperger R; Schlegel J; Förstl H; Martins RN; Kurz A
Hum Mol Genet; 2006 Aug; 15(16):2446-56. PubMed ID: 16825285
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
Ertekin-Taner N; Ronald J; Asahara H; Younkin L; Hella M; Jain S; Gnida E; Younkin S; Fadale D; Ohyagi Y; Singleton A; Scanlin L; de Andrade M; Petersen R; Graff-Radford N; Hutton M; Younkin S
Hum Mol Genet; 2003 Dec; 12(23):3133-43. PubMed ID: 14559775
[TBL] [Abstract][Full Text] [Related]
8. Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.
Myers AJ; Marshall H; Holmans P; Compton D; Crook RJ; Mander AP; Nowotny P; Smemo S; Dunstan M; Jehu L; Wang JC; Hamshere M; Morris JC; Norton J; Chakraventy S; Tunstall N; Lovestone S; Petersen R; O'Donovan M; Jones L; Williams J; Owen MJ; Hardy J; Goate A
Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):29-37. PubMed ID: 14681909
[TBL] [Abstract][Full Text] [Related]
9. Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels.
Reitz C; Cheng R; Schupf N; Lee JH; Mehta PD; Rogaeva E; St George-Hyslop P; Mayeux R
Neurobiol Aging; 2012 Jan; 33(1):199.e13-7. PubMed ID: 20724036
[TBL] [Abstract][Full Text] [Related]
10. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.
Liu RM; van Groen T; Katre A; Cao D; Kadisha I; Ballinger C; Wang L; Carroll SL; Li L
Neurobiol Aging; 2011 Jun; 32(6):1079-89. PubMed ID: 19604604
[TBL] [Abstract][Full Text] [Related]
11. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Baker M; Adamson J; Ronald J; Blangero J; Hutton M; Younkin SG
Science; 2000 Dec; 290(5500):2303-4. PubMed ID: 11125143
[TBL] [Abstract][Full Text] [Related]
12. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
[TBL] [Abstract][Full Text] [Related]
13. The PLAU P141L single nucleotide polymorphism is associated with collateral circulation in patients with coronary artery disease.
Duran J; Sánchez-Olavarría P; Mola M; Götzens V; Carballo J; Martín-Pelegrina E; Petit M; García Del Blanco B; García-Dorado D; de Anta JM
Rev Esp Cardiol (Engl Ed); 2014 Jul; 67(7):552-7. PubMed ID: 24952395
[TBL] [Abstract][Full Text] [Related]
14. Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits.
Ozturk A; Minster RL; DeKosky ST; Kamboh MI
Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):79-82. PubMed ID: 16967469
[TBL] [Abstract][Full Text] [Related]
15. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
Katzov H; Chalmers K; Palmgren J; Andreasen N; Johansson B; Cairns NJ; Gatz M; Wilcock GK; Love S; Pedersen NL; Brookes AJ; Blennow K; Kehoe PG; Prince JA
Hum Mutat; 2004 Apr; 23(4):358-67. PubMed ID: 15024730
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
Miyashita A; Arai H; Asada T; Imagawa M; Matsubara E; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Kuwano R;
Hum Mol Genet; 2007 Dec; 16(23):2854-69. PubMed ID: 17761686
[TBL] [Abstract][Full Text] [Related]
18. The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease.
Bagnoli S; Tedde A; Cellini E; Rotondi M; Nacmias B; Sorbi S
Neurogenetics; 2005 Feb; 6(1):53-4. PubMed ID: 15616835
[No Abstract] [Full Text] [Related]
19. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease.
Wu W; Jiang H; Wang M; Zhang D
Am J Alzheimers Dis Other Demen; 2013 Aug; 28(5):517-23. PubMed ID: 23813610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
